Back
ProKidney Corp. 10K Form
Sell
46
PROK
ProKidney Corp.
Last Price:
$2.34
Seasonality Move:
-10.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PROK News And Ratings
See the #1 stock for the next 7 days that we like better than PROK
PROK Financial Statistics
Sales & Book Value
| Annual Sales: | $76K |
|---|---|
| Cash Flow: | $-31.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-7.41 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.54450 |
|---|---|
| Net Income (TTM): | $-159.2M |
| Gross Margin: | $-4.3M |
| Return on Equity: | -42.51% |
| Return on Assets: | -38.9% |
ProKidney Corp. Earnings Forecast
Key ProKidney Corp. Financial Ratios
-
The Gross Profit Margin over the past 4 years for PROK is -5,606.58%.
-
The Selling, General & Administrative Expenses for PROK have been equal to 73,794.74% of Gross Profit Margin.
-
The Research & Development expenses have been 167,984.21% of Revenue.
-
The Net Earning history of PROK is -214,914.47% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 1 years.
ProKidney Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PROK |
| Website: | prokidney.com |
Debt
| Debt-to-Equity Ratio: | -0 |
|---|---|
| Current Ratio: | 10.32 |
| Quick Ratio: | 9.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PROK Technical Analysis vs Fundamental Analysis
Sell
46
ProKidney Corp. (PROK)
is a Sell
Is ProKidney Corp. a Buy or a Sell?
-
ProKidney Corp. stock is rated a SellThe current ProKidney Corp. [PROK] share price is $2.34. The Score for PROK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.